Inventor · Martinsried, DE

Robert Rauchenberger

25Patents
9h-index
38Co-inventors
75Inventor score

Filing activity: Nov 15, 2001 → Feb 22, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7993645B2 Human anti-IL-23 antibodies, compositions, methods and uses Chemistry; Metallurgy 41 Active
US7935344B2 Human anti-IL-23 antibodies, compositions, methods and uses Chemistry; Metallurgy 37 Active
US8106177B2 Nucleic acids encoding human anti-IL-23 antibodies Chemistry; Metallurgy 31 Active
US9353181B2 Human anti-IL-23 antibodies, compositions, methods and uses Chemistry; Metallurgy 20 Active
US8221760B2 Methods of treatment using human anti-IL-23 antibodies Chemistry; Metallurgy 19 Active
US9255153B2 Polynucleotides encoding Toll-Like Receptor 3 antagonists Chemistry; Metallurgy 10 Active
US8519107B2 IL-17A antibodies Chemistry; Metallurgy 10 Active
US9522957B2 Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists Chemistry; Metallurgy 10 Active
US9481731B2 Toll-like receptor 3 antagonists Chemistry; Metallurgy 9 Active
US7521047B2 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells Chemistry; Metallurgy 7 Expired
US10030070B2 Human anti-IL-23 antibodies, compositions, methods and uses Chemistry; Metallurgy 7 Active
US9783607B2 Human anti-IL-23 antibodies, compositions, methods and uses Chemistry; Metallurgy 7 Active
US9238693B2 Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies Chemistry; Metallurgy 3 Active
US8409567B2 Toll-like receptor 3 antagonists Chemistry; Metallurgy 2 Active
US8540986B2 Toll-like receptor 3 antagonists Chemistry; Metallurgy 2 Active
US8460659B2 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases Chemistry; Metallurgy 2 Active
US10179810B2 Anti-IGF antibodies Emerging Cross-Sectional Technologies 1 Active
US9856316B2 Antibodies targeting M-CSF Chemistry; Metallurgy 0 Active
US9428577B2 Platelet-derived growth factor B specific antibodies and compositions and uses thereof Chemistry; Metallurgy 0 Active
US10954297B2 Methods of treatment using human anti-IL-23 antibodies Chemistry; Metallurgy 0 Active
US10081675B2 Antibodies targeting M-CSF Chemistry; Metallurgy 0 Active
US9932404B2 Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist Chemistry; Metallurgy 0 Active
US12129293B2 Medical device for administering anti-IL-23 antibodies Chemistry; Metallurgy 0 Active
US11939375B2 Medical device for administering anti-IL-23 antibodies General 0 Revoked
US11299538B2 Anti-IGF antibodies Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.